Conditional chronic overexpression of the Cyclin Dependent Kinase Inhibitor 1A (CDKN1A-known as p21) in the human ALT osteosarcoma cell line Saos-2 deregulates replication licensing and generates increased rates of structural chromosome instability [49]. This evidence concerns the gene CDKN1A and osteosarcoma.